Category Archives: Pr Newswire

MDJM LTD Appoints Professor Duncan Murray Campbell to Promote Cultural Initiatives in the UK

LETHAM, Scotland, Aug. 15, 2024 /PRNewswire/ — MDJM LTD (Nasdaq: MDJH) (the “Company” or “MDJM”), an integrated global culture-driven asset management company, announced today the appointment of Professor Duncan Murray Campbell to the Expert Committee of its wholly owned subsidiary, MD Local Global Limited, a United Kingdom Company. Professor Campbell’s extensive expertise in Chinese cultural […]

MEGA MATRIX CORP. Announces Second Quarter 2024 Financial Results

PALO ALTO, Calif., Aug. 15, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced financial results for its second quarter ended June 30, 2024.  Operating Highlights User recharge totaled $15.8 million in the first half of 2024, with 62.0% generated from the U.S. In the first half of 2024, […]

CHIVAS REGAL SCORES BIG WITH MULTI-YEAR GLOBAL ARSENAL PARTNERSHIP

The iconic blended Scotch whisky will become the club’s Official Whisky Partner celebrating their shared ambition for collective success ahead of the new season To celebrate the partnership, Chivas Regal and Arsenal buy a pre-match round for the local community and spirited Gooners with a Chivas Highball giveaway across local pubs LONDON, Aug. 15, 2024 /PRNewswire/ […]

Invivyd Reports Second Quarter 2024 Financial Results and Recent Business Highlights

PEMGARDA™ launched commercially in Q2 2024 with $2.3 million of net product revenue Notable acceleration of commercial results in early Q3 2024, with the anticipated peak fall/winter respiratory virus season approaching New commercial leadership with Chief Commercial Officer, Tim Lee, an experienced biopharmaceutical leader with demonstrated commercial success Achieved Medicare and Medicaid coverage, rapid growth […]

Kent Kresa to Retire from MannKind’s Board of Directors; Steven B. Binder to be Appointed to the Board

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that Kent Kresa has decided to retire from MannKind’s Board of Directors effective September […]

Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr

WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced the successful dosing of the first patient in its open-label Phase 1 imaging and dosimetry clinical trial of its uPAR-targeted imaging radiopharmaceutical MNPR-101-Zr. MNPR-101-Zr was well-tolerated with no […]

IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update

Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immuno-oncology therapy, today reported financial results for the three and six months ended June 30, 2024. The Company also provided an update on its clinical […]

VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Initiated Phase 2b trial of VYN201 in nonsegmental vitiligo, with top-line results expected in mid-2025 Phase 1a SAD/MAD trial of VYN202 progressing, with data from the SAD and MAD portions expected in Q3 and Q4 2024, respectively Balance sheet expected to fund key clinical milestones for VYN201 and VYN202 through the end of 2025 BRIDGEWATER, […]

Four Seasons Education Announces Cash Dividend

SHANGHAI, Aug. 14, 2024 /PRNewswire/ — Four Seasons Education (Cayman) Inc. (“Four Seasons Education” or the “Company”) (NYSE: FEDU), a tourism and education-related service provider in China, today announced that its Board of Directors has declared a cash dividend of US$0.23 per ordinary share, or US$2.30 per American Depositary Share (“ADS”). The dividend is expected […]

NEOM McLaren Extreme E Joins Vantage Markets to Ignite “Reborn” Phase of the “Reborn a Trader” Campaign

LONDON, Aug. 14, 2024 /PRNewswire/ — Multi-asset broker Vantage Markets (“Vantage”) is proud to announce the “Reborn” phase of its “Reborn a Trader” campaign in collaboration with the NEOM McLaren Extreme E team. This latest collaboration features two exclusive interviews with NEOM McLaren Extreme E drivers, Mattias Ekström and Cristina Gutierrez, who share their personal […]